Lipella Pharmaceuticals, Inc. (LIPO) Stock Statistics & Valuation Metrics

Lipella Pharmaceuticals, Inc. has a market cap or net worth of $12.87M. The enterprise value is -$4.19B.

Lipella Pharmaceuticals, Inc. has 4,467,395 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lipella Pharmaceuticals, Inc.’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is -252.18%.

The current PE Ratio of Lipella Pharmaceuticals, Inc. is -0.64. Lipella Pharmaceuticals, Inc.’s PEG ratio is >-0.01.

In the last 12 months, Lipella Pharmaceuticals, Inc. had revenue of 536.36K and earned -5.02M in profits. Earnings per share was -4.79.

In the last 12 months, operating cash flow was -1.43B and capital expenditures 0.00, giving a free cash flow of -1.43B billion.

Lipella Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Lipella Pharmaceuticals, Inc. upcoming earnings date is May 15, 2023, TBA Not Confirmed.

Lipella Pharmaceuticals, Inc. as a current ratio of 3.47, with Debt / Equity ratio of 0.59%

In the past 12 months, Lipella Pharmaceuticals, Inc. has paid 0.00 in taxes.

Lipella Pharmaceuticals, Inc. EV to EBITDA ratio is -0.21, with an EV/FCF ratio of -0.27.

Lipella Pharmaceuticals, Inc. has $4.23B in cash and marketable securities with $24.00M in debt, giving a net cash position of -$4.20B billion.

Gross margin is -1.94%, with operating margin of -947.23%, and net profit margin of -935.25%.

The average price target for Lipella Pharmaceuticals, Inc. is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy